- Home
- MLNK vs PLSE Comparison
MLNK vs PLSE Comparison
Compare MLNK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLNK
- PLSE
- Stock Information
- Founded
- MLNK 1998
- PLSE 2014
- Country
- MLNK United States
- PLSE United States
- Employees
- MLNK N/A
- PLSE N/A
- Industry
- MLNK Computer Software: Prepackaged Software
- PLSE Medical/Dental Instruments
- Sector
- MLNK Technology
- PLSE Health Care
- Exchange
- MLNK Nasdaq
- PLSE Nasdaq
- Market Cap
- MLNK 1.5B
- PLSE 1.3B
- IPO Year
- MLNK 2021
- PLSE 2016
- Fundamental
- Price
- MLNK $18.31
- PLSE $16.73
- Analyst Decision
- MLNK Hold
- PLSE
- Analyst Count
- MLNK 7
- PLSE 0
- Target Price
- MLNK $21.64
- PLSE N/A
- AVG Volume (30 Days)
- MLNK 254.1K
- PLSE 217.1K
- Earning Date
- MLNK 03-06-2025
- PLSE 03-27-2025
- Dividend Yield
- MLNK N/A
- PLSE N/A
- EPS Growth
- MLNK N/A
- PLSE N/A
- EPS
- MLNK N/A
- PLSE N/A
- Revenue
- MLNK $316,298,000.00
- PLSE N/A
- Revenue This Year
- MLNK $7.59
- PLSE N/A
- Revenue Next Year
- MLNK $8.13
- PLSE N/A
- P/E Ratio
- MLNK N/A
- PLSE N/A
- Revenue Growth
- MLNK 4.18
- PLSE N/A
- 52 Week Low
- MLNK $16.49
- PLSE $6.60
- 52 Week High
- MLNK $25.33
- PLSE $25.00
- Technical
- Relative Strength Index (RSI)
- MLNK 40.28
- PLSE 47.07
- Support Level
- MLNK $18.90
- PLSE $15.29
- Resistance Level
- MLNK $18.78
- PLSE $17.85
- Average True Range (ATR)
- MLNK 0.46
- PLSE 1.08
- MACD
- MLNK -0.10
- PLSE 0.13
- Stochastic Oscillator
- MLNK 29.55
- PLSE 58.97
Stock Price Comparison Chart: MLNK vs PLSE
About MLNK MeridianLink Inc.
MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.